Condition: Head & Neck Squamous Cell Carcinoma · Sponsor: Rigshospitalet, Denmark
Radiotherapy of head-neck cancer is associated with significant side effects. Using daily online adaptive radiotherapy to account for the changing anatomy, radiation to organs at risk can be lowered. We will investigate whether this is feasible and associated with a reduction in the risk of toxicity.
This description comes directly from the study's public registry record.
Jeppe Friborg, MD, PhD · +45 35458189 · jeppe.friborg@regionh.dk
Anne Lindegaard, MD · +45 35456107 · anne.marie.mira.lindegaard@regionh.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07506902